237 related articles for article (PubMed ID: 9152289)
1. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation.
Brauner R; Adan L; Souberbielle JC; Esperou H; Michon J; Devergie A; Gluckman E; Zucker JM
J Pediatr; 1997 May; 130(5):785-92. PubMed ID: 9152289
[TBL] [Abstract][Full Text] [Related]
2. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency.
Holm K; Nysom K; Rasmussen MH; Hertz H; Jacobsen N; Skakkebaek NE; Krabbe S; Müller J
Bone Marrow Transplant; 1996 Jul; 18(1):163-70. PubMed ID: 8832010
[TBL] [Abstract][Full Text] [Related]
3. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
[TBL] [Abstract][Full Text] [Related]
4. Changes in height, weight and plasma leptin after bone marrow transplantation.
Couto-Silva AC; Trivin C; Esperou H; Michon J; Fischer A; Brauner R
Bone Marrow Transplant; 2000 Dec; 26(11):1205-10. PubMed ID: 11149732
[TBL] [Abstract][Full Text] [Related]
5. Growth and growth hormone secretion after bone marrow transplantation.
Brauner R; Fontoura M; Zucker JM; Devergie A; Souberbielle JC; Prevot-Saucet C; Michon J; Gluckman E; Griscelli C; Fischer A
Arch Dis Child; 1993 Apr; 68(4):458-63. PubMed ID: 8503666
[TBL] [Abstract][Full Text] [Related]
6. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone.
Giorgiani G; Bozzola M; Locatelli F; Picco P; Zecca M; Cisternino M; Dallorso S; Bonetti F; Dini G; Borrone C
Blood; 1995 Jul; 86(2):825-31. PubMed ID: 7606014
[TBL] [Abstract][Full Text] [Related]
7. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone function and treatment following bone marrow transplant for neuroblastoma.
Olshan JS; Willi SM; Gruccio D; Moshang T
Bone Marrow Transplant; 1993 Oct; 12(4):381-5. PubMed ID: 8275038
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
[TBL] [Abstract][Full Text] [Related]
10. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
12. Growth in children after bone marrow transplantation for acute leukemia.
Huma Z; Boulad F; Black P; Heller G; Sklar C
Blood; 1995 Jul; 86(2):819-24. PubMed ID: 7606013
[TBL] [Abstract][Full Text] [Related]
13. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) concentrations compared to stimulated growth hormone (GH) in the evaluation of children treated for malignancy.
Cicognani A; Cacciari E; Pession A; Pasini A; De Iasio R; Gennari M; Alvisi P; Pirazzoli P
J Pediatr Endocrinol Metab; 1999; 12(5):629-38. PubMed ID: 10703534
[TBL] [Abstract][Full Text] [Related]
15. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency.
Hasegawa Y; Hasegawa T; Aso T; Kotoh S; Nose O; Ohyama Y; Araki K; Tanaka T; Saisyo S; Yokoya S
Eur J Endocrinol; 1994 Jul; 131(1):27-32. PubMed ID: 7518726
[TBL] [Abstract][Full Text] [Related]
17. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
18. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours.
Weinzimer SA; Homan SA; Ferry RJ; Moshang T
Clin Endocrinol (Oxf); 1999 Sep; 51(3):339-45. PubMed ID: 10469014
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment.
Noordam C; van der Burgt I; Sweep CG; Delemarre-van de Waal HA; Sengers RC; Otten BJ
Clin Endocrinol (Oxf); 2001 Jan; 54(1):53-9. PubMed ID: 11167926
[TBL] [Abstract][Full Text] [Related]
20. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
